Concepedia

Reactogenicity Biomarkers

"Reactogenicity Biomarker" is a measurable biological indicator that objectively reflects the magnitude and nature of the host's immune and physiological responses to vaccine administration, distinguishing it from general safety endpoints by specifically quantifying the mechanisms and manifestations underlying vaccine-induced reactogenicity.

14

Publications

592

Citations

135

Authors

46

Institutions

Publications per year

2017–2026

12

Variants

Reactogenicity Biomarker

Parents

Publications

14

The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population

Guido Moens, Isabelle Desombere, J Dewijngaert et al. · Vaccine · 2002 · 93 citations

, , +16

Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans

Wivine Burny, Arnaud Marchant, Caroline Hervé et al. · Vaccine · 2019 · 76 citations · Full text

, , +17

Dengue Virus Type 2 Vaccine: Reactogenicity and Immunogenicity in Soldiers

William H. Bancroft, Robert McN. Scott, Kenneth H. Eckels et al. · The Journal of Infectious Diseases · 1984 · 75 citations

, , +15

Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis

Lars Erik Bartels, Christian Gytz Ammitzbøll, J.B. Andersen et al. · Rheumatology International · 2021 · 73 citations · Full text

, , +16

Can reactogenicity predict immunogenicity after COVID-19 vaccination?

Young Hoon Hwang, Kyoung‐Ho Song, Yunsang Choi et al. · The Korean Journal of Internal Medicine · 2021 · 61 citations · Full text

, , +17

1–5 of 14

Authors

135

  1. MT
    Masaaki Takeuchi

    University of Occupational and Environmental Health Japan, Japan

    2 publications · 62 citations

    2

    h-index

  2. GL
    Geert Leroux‐Roels

    Ghent University Hospital, Belgium

    2 publications · 130 citations

    2

    h-index

  3. AN
    Akemi Nakazono

    University of Occupational and Environmental Health Japan, Japan

    2 publications · 62 citations

    2

    h-index

  4. YH
    Yukie Higa

    University of Occupational and Environmental Health Japan, Japan

    2 publications · 62 citations

    2

    h-index

  5. YN
    Yosuke Nabeshima

    University of Occupational and Environmental Health Japan, Japan

    2 publications · 62 citations

    2

    h-index

1–5 of 135

Institutions

46

  1. GlaxoSmithKline (Belgium)

    Wavre, Belgium

    3 h-index

    12 publications

    907 citations

  2. Ghent University Hospital

    Ghent, Belgium

    2 h-index

    3 publications

    223 citations

  3. University of Occupational and Environmental Health Japan

    Kitakyushu, Japan

    2 h-index

    10 publications

    310 citations

  4. Asan Medical Center

    Seoul, South Korea

    1 h-index

    11 publications

    143 citations

  5. KU Leuven

    Leuven, Belgium

    1 h-index

    1 publications

    93 citations

  6. University of Surrey

    Guildford, United Kingdom

    1 h-index

    6 publications

    222 citations

  7. Aarhus University

    Aarhus, Denmark

    1 h-index

    7 publications

    511 citations

  8. Max Planck Institute for Infection Biology

    Berlin, Germany

    1 h-index

    4 publications

    148 citations

1–8 of 46

Venues

  1. Vaccine

    3 publications · 189 citations

    3

    h-index

  2. Scientific Reports

    2 publications · 50 citations

    2

    h-index

  3. npj Digital Medicine

    1 publications · 37 citations

    1

    h-index

  4. medRxiv

    Repository · 1 publications · 18 citations

    1

    h-index

  5. The Journal of Infectious Diseases

    JID · 1 publications · 75 citations

    1

    h-index

1–5